Imeik Technology Development Co.,Ltd. (SHE: 300896)

Market Cap	40.87B
Revenue (ttm)	3.07B
Net Income (ttm)	2.02B
Shares Out	301.27M
EPS (ttm)	6.68
PE Ratio	20.30
Forward PE	16.05
Dividend	n/a
Ex-Dividend Date	Apr 29, 2024

Volume	980,608
Open	140.64
Previous Close	136.77
Day's Range	134.55 - 140.64
52-Week Range	134.55 - 317.85
Beta	1.09
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Imeik Technology Development Co.,Ltd.

Imeik Technology Development Co.,Ltd. engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China. The company offers aesthetic medicine products, including cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere, poly facial implant thread, medical sodium hyaluronate-hydroxypropyl methylcellulose gel, sodium hyaluronate composite solution for injection, modified sodium hyaluronate gel for injection, and medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 910
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300896

Financial Performance

In 2023, Imeik Technology Development Co.,Ltd.'s revenue was 2.87 billion, an increase of 47.99% compared to the previous year's 1.94 billion. Earnings were 1.86 billion, an increase of 47.08%.